Systemic sclerosis & Raynaud's

Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort

Arthritis Care Res (Hoboken)Published Prospective cohort study

Authors' conclusion

GIT manifestations are common in SSc and negatively impact QoL, physical function, and employment but are not directly associated with increased death.

Study context

Population
Consecutive patients with systemic sclerosis (SSc) from the Australian Scleroderma Cohort Study who completed the UCLA gastrointestinal tract (GIT) questionnaire, 2015–2021
Participants
907 consecutive patients
Exposure
Severity of GIT symptoms: moderate and severe to very severe vs mild
Outcome
Prevalence of GIT symptoms and their association with survival and patient-reported outcomes
Methodological detailsconsecutive patients, multivariable population-averaged panel models (GEE), multivariable Cox proportional hazard regression
  • Consecutive patients
  • Multivariable population-averaged panel models (GEE)
  • Multivariable Cox proportional hazard regression

Main finding

As reported in the abstract

Prevalence of GIT symptoms

GIT symptoms reported

87%

Moderate to very severe symptoms of reflux, distension, diarrhea and constipation

46% to 52%

Observational data: associations, not effects.

Further findings

Total UCLA GIT scores and patient-reported outcomes

Higher total UCLA GIT scores associated with worse quality of life (QoL), physical function, fatigue, anxiety and depression
P < 0.001

Multivariable GEE: moderate and severe to very severe total, reflux and distension scores vs mild

Associated with worse physical function, QoL, fatigue, anxiety and depression vs mild scores
P < 0.05

Unemployment

Severe total scores and diarrhea scores more likely unemployed vs mild scores
P < 0.05

Death

UCLA GIT total scores not independently associated with death

Original publication

Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort. Arthritis Care Res (Hoboken). Published 4 October 2024. doi:10.1002/acr.25426

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.